What is LOPJLB’s current signal on PTN?

LOPJLB’s latest quantitative signal on Palatin Technologies, Inc. (PTN) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is PTN in?

Palatin Technologies, Inc. (PTN) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Palatin Technologies, Inc. (PTN) do?

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial…

Where is Palatin Technologies, Inc. based / listed?

Palatin Technologies, Inc. is based in US, listed on NASDAQ.

Palatin Technologies, Inc. (PTN) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $18M
Avg volume: 17.3K
Beta: -0.07
P/E (TTM): -2.18

Short % float: 21.45%
Days to cover: 29.8
SI change: -2.3%

1W: +2.11%
1M: +31.78%
3M: -31.72%
YTD: -36.70%

vs SPY 1W: +3.30%
vs SPY 1M: +28.46%
vs SPY 3M: -34.11%
vs SPY YTD: -48.45%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Palatin Technologies, Inc. (PTN)

Key stats

Sector peers

Prediction markets

EARNINGS HISTORY

Company news